Skip to main content
main-content

Zeitschrift

Cancer Immunology, Immunotherapy

Cancer Immunology, Immunotherapy 12/2002

Ausgabe 12/2002

Inhaltsverzeichnis ( 6 Artikel )

01.02.2002 | Original Article | Ausgabe 12/2002

Sodium butyrate enhances complement-mediated cell injury via down-regulation of decay-accelerating factor expression in colonic cancer cells

Akira Andoh, Mitsue Shimada, Yoshio Araki, Yoshihide Fujiyama, Tadao Bamba

01.02.2002 | Original Article | Ausgabe 12/2002

SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients

Robert K. Bright, Eric T. Kimchi, Michael H. Shearer, Ronald C. Kennedy, Harvey I. Pass

01.02.2002 | Original article | Ausgabe 12/2002

Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells

Mariko Kawakami, Koji Kawakami, Raj K. Puri

01.02.2002 | Original article | Ausgabe 12/2002

Induction of intratumoral tumor necrosis factor by a synthetic lipid A analog, ONO-4007, with less tolerance in repeated administration and its implication in potent antitumor effects with low toxicity

Motonobu Satoh, Kazusa Tsurumaki, Hideaki Kagehara, Masatoshi Yamazaki

01.02.2002 | Original Article | Ausgabe 12/2002

Generation of anti-idiotypic reagents in the EGFRvIII tumor-associated antigen system

Carol J. Wikstrand, Vanessa R. Cole, Laura E. Crotty, John H. Sampson, Darell D. Bigner

01.02.2002 | Original Article | Ausgabe 12/2002

Tumor-associated antigen human chorionic gonadotropin beta contains numerous antigenic determinants recognized by in vitro-induced CD8+ and CD4+ T lymphocytes

Virginie Dangles, Ilan Halberstam, Antonio Scardino, Jeannine Choppin, Mireille Wertheimer, Sophie Richon, Erwann Quelvennec, Romain Moirand, Jean-Gérard Guillet, Kostas Kosmatopoulos, Dominique Bellet, Dominique Zeliszewski

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise